Bacitracin: Clinical Trials

30 trials of Bacitracin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 7 withdrawn, 4 terminated, 1 not yet recruiting. 13 Phase 4, 7 Not applicable, 3 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 413Completed 7, Terminated 3, Withdrawn 2, Unknown 1
Not applicable7Completed 3, Withdrawn 3, Not yet recruiting 1
Phase 23Completed 3
Phase 33Completed 3
Phase 12Completed 1, Withdrawn 1
Early Phase 11Terminated 1

Follow Bacitracin: new trials by email Literature Review of Bacitracin trials Research Report on Bacitracin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sebum Metabolomics and Lipidomics for Clinical Applications
Sebutape sampling, Bacitracin/Polymyxin B/Neomycin ointment (Yentuogin ointment) - Acne, Atopic Dermatitis
Not applicableNot yet recruitingNational Taiwan University Hospital2002026-04-012026-04-24
The Safety and Microbial Changes in the Use of Intranasal Neosporin®
Intranasal application of Polymyxin B Sulfate 500,000 IU, Bacitracin zinc 40,000 IU, Neomycin Sulfate 0.35g neomycin base - Teste the Safety of (Polymyxin B Sulfate 500,000 IU, Bacitracin Zinc 40,000 IU, Neomycin Sulfate 0.35g Neomycin Base) Intranasally
Not applicableCompletedHospital Universitario Dr. Jose E. Gonzalez122025-02-132026-07-14
Mupirocin 2% Ointment Vs Spray Antibiotics on Temporary Hemodialysis Catheter
Local antibiotic spray Neomycin sulphate 165,000 IU + Bacitracin zinc 12,500 IU, Mupirocin 2% ointment - Hemodialysis Complication, Hemodialysis Catheter Infection
Phase 2 / Phase 3CompletedFuture University in Egypt1502023-04-102023-08-22
Impaired Risk Awareness During Intoxication in DUI Offenders
Blood alcohol concentration (BAC) discrimination training, Performance feedback training, Blood alcohol concentration (BAC) discrimination training for controls - Alcohol Use
Not applicableCompletedMark Fillmore1122022-02-022026-05-12
A Comparison of the Outcomes of Distal Fingertip Amputations Treated With Either Artificial (Xeroform) or Biological Dressings
Bacitracin, Skin Graft - Finger Injuries, Amputation, Traumatic
WithdrawnNYU Langone Health2018-12-242020-05-29
The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown
Medicinal honey, Bacitracin - Skin Infection
Phase 4CompletedHenry Ford Health System172018-10-252026-01-07
Topical Antibiotic Prophylaxis for Eyelids
Topical Antibiotic Product, Topical Non-Antibiotic Ointment - Antibiotic Side Effect, Eyelid; Wound
Phase 4CompletedUniversity of California, San Francisco4012017-10-022020-07-21
Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy
Normal saline, Cefazolin, Skin biopsy - Breast Implant Infection, Mammoplasty
Phase 1CompletedWashington University School of Medicine192017-07-252019-02-08
Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.
polymixin/bacitracin, cephalexin, or levofloxacin, or clindamycin, Saline - Sick Sinus Syndrome, Complete Heart Block
Phase 3CompletedVanderbilt University Medical Center10102016-04-012022-05-09
The Burn Glove Trial - Hand Burn Dressing Pilot
Aquacel® Ag Burn Glove, Mepilex® Transfer Ag, antibiotic - Burns
Not applicableWithdrawnSouthern Illinois University2015-12-012016-07-21
Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation
Chlorhexidine irrigation, triple antibiotic irrigation - Breast Cancer
Not applicableCompletedVanderbilt University Medical Center882015-12-012022-01-26
Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
2% mupirocin ointment, Chlorhexidine wash, Hygiene protocol - Methicillin-Resistant Staphylococcus Aureus, Recurrence
Phase 4UnknownClinical Directors Network2782015-10-012017-07-21
Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients
Topical Tranexamic Acid 5% with bacitracin, Topical Tranexamic Acid 25% with bacitracin - Arteriovenous Fistula
Phase 4CompletedCalifornia Institute of Renal Research172014-04-012017-09-25
Patients Response to Early Switch To Oral:Osteomyelitis Study
oral antibiotics, intravenous antibiotics - Osteomyelitis
Early Phase 1TerminatedJulio Ramirez112014-03-062021-04-06
Comparison of Collagenase With Antibiotic Ointment of Minor Partial Thickness Burns
Collagenase Santyl, Bacitracin - Burn, Partial Thickness
Phase 4TerminatedUniversity of Kansas Medical Center202013-09-302024-07-10
Prevention of Arrhythmia Device Infection Trial (PADIT)
Incremental, Conventional - Arrhythmia
Phase 4CompletedPopulation Health Research Institute128142012-12-012019-06-24
Using Santyl or Bacitracin on Second Degree Burns
Collagenase Santyl, Bacitracin - Burn, Partial Thickness
Phase 4WithdrawnHealthpoint2012-03-012012-05-16
Comparison of Wound Bed Establishment in Facial Burns
Enzymatic agent, Bacitracin - Burns
Phase 4CompletedUniversity of Louisville102012-02-012017-08-28
The Relationship of Hemoglobin A1c and Diabetic Wound Healing
Bacitracin, AmeriGel®, Vitamin C - Diabetes, Type 1, Diabetes, Type 2
Phase 4TerminatedSusan Hassenbein22012-02-012017-12-12
Prevention of Arrhythmia Device Infection Trial (PADIT)
Incremental, Cefazolin - Arrhythmia
Phase 4CompletedPopulation Health Research Institute2412011-05-012014-10-10

Showing 20 of 30. Sign in to see all of them.

Conditions studied

Burns (6)  ·  Arrhythmias, Cardiac (2)  ·  Cicatrix (2)  ·  Infections (2)  ·  Acne Vulgaris (1)  ·  Alcohol Drinking (1)  ·  Amputation, Traumatic (1)  ·  Arteriovenous Fistula (1)  ·  Breast Neoplasms (1)  ·  Catheter-Related Infections (1)  ·  Cellulitis (1)  ·  Dermatitis, Allergic Contact (1)  ·  Dermatitis, Atopic (1)  ·  Dermatitis, Seborrheic (1)  ·  Diabetes Mellitus, Type 1 (1)

Sponsors

Population Health Research Institute (3)  ·  Lahey Clinic (2)  ·  Vanderbilt University Medical Center (2)  ·  California Institute of Renal Research (1)  ·  Clinical Directors Network (1)  ·  Fraser Health (1)  ·  Future University in Egypt (1)  ·  Healthpoint (1)  ·  Henry Ford Health System (1)  ·  Hospital Universitario Dr. Jose E. Gonzalez (1)  ·  Julio Ramirez (1)  ·  Mark Fillmore (1)  ·  Mekos Laboratories AS (1)  ·  MetroHealth Medical Center (1)  ·  Mylan Inc. (1)

Countries

United States (22)  ·  Canada (4)  ·  Egypt (1)  ·  Mexico (1)

Top investigators

Dhaval Bhavsar, MD (2)  ·  Adrian Camacho Ortiz, MD, PhD (1)  ·  Andrew Krahn, MD (1)  ·  Carlee R. Lehna, PhD, APRN-BC (1)  ·  Charles Yowler, MD (1)  ·  Christopher Ellis, M.D. (1)  ·  David Seligson, MD (1)  ·  Doaa ElBohy, PhD (1)  ·  Dr. Andrew Krahn (1)  ·  Dr. Andrew Krahn, M.D (1)  ·  Eric Davis, MD (1)  ·  Herbert B Slade, MD (1)  ·  Jacques Hacquebord (1)  ·  James R Townley, MD (1)

Results publications

PMID 15276398, PMID 15840453, PMID 19588358, PMID 22530208, PMID 30545448, PMID 31806127, PMID 34859113, PMID 35342110, PMID 36960716, PMID 4902833, PMID 8948280

NIH funding

R01AA028447 (1)